Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 16, 2021

Digital health technologies to significantly impact clinical trials over the next five years: Poll

The advent of wearable and digital health technologies is enabling the collection of multi-dimensional data during the entire duration of a clinical trial.

These technologies are helping to design better clinical trials and establish novel endpoints.

In a poll Verdict has conducted to assess the impact of digital health technologies on clinical trials over the next five years, a majority 64% foresaw a significant impact.

The impact will be moderate, according to 20% of the respondents, while they have no impact according to 9% of the respondents.

A lesser 7% of the respondents opined that digital health technologies have minimal impact on clinical trials.

Impact of digital health technologies

The analysis is based on 319 responses received from the readers of Clinical Trials Arena, a Verdict network site, between 08 February and 18 May 2021.

Content from our partners
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

Impact of digital health technologies on clinical trials

Digital health technologies, in combination with emerging technologies such as artificial intelligence (AI) and cloud computing, are transforming the way clinical trials are designed or even conducted. Clinical trials often face challenges such as patient enrolment, rising costs, and scattered data sets making the drug discovery process lengthy and expensive.

The coronavirus pandemic highlighted the limitations of the existing clinical trial processes and the need to transform the processes. Meeting patient enrolment number is currently a challenge for approximately 90% of clinical trials. Virtual clinical trials along with technologies such as AI can combine current patient data with historical trial data to perform the testing with a limited cohort.

Further, AI tools such as machine learning can help in matching patient profiles to trials by analysing information from digital devices such as wearables and other medical devices to create trials with better design. Digitisation and decentralised clinical trials are expected to be way forward to improve trial outcomes, ensure patient safety, and ensure better data aggregation and analysis.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU